https://doi.org/10.55788/fbb80a87
Recognising modifiable and non-modifiable paediatric causative factors can aid in identifying children at an increased risk of IBD. The systematic review, presented by Dr Nisha Thacker (University of Newcastle, Australia), aimed to explore the relationship between dietary habits and environmental exposure and paediatric IBD diagnosis [1]. Out of the 4,763 studies examined, the researchers analysed 35 observational studies that included 461,490 participants.
The study found a higher likelihood of paediatric IBD diagnosis among individuals who were exposed to antibiotics in early childhood (OR 4.54; 95% CI 1.47–14.02; P=0.009), those who had 1-4 antibiotic courses (OR 2.55; 95% CI 1.79–3.65; P≤0.001), and those who had >4 antibiotic courses during childhood (OR 3.46; 95% CI 2.14–5.60; P≤0.001).
Additional factors, including high socioeconomic status (OR 2.55; 95% CI 1.40–4.63; P=0.002) and urban living (OR 1.70; 95% CI 0.96–3.00; P=0.067), significantly increased the chances of paediatric IBD.
Dietary patterns also played a significant role. Regular or high vegetable intake was associated with a lower risk of paediatric IBD (OR 0.47; 95% CI 0.2–1.06; P=0.067), whereas regular intake of sugary beverages and candies conferred a higher risk (OR 2.02; 95% CI 1.06–3.85; P=0.033).
In conclusion, the understanding of paediatric IBD risk factors is evolving. It is becoming increasingly evident that early-life environmental and dietary exposures significantly influence these risks. Prevention strategies should be comprehensive, considering antibiotic use, dietary habits, lifestyle factors, and microbiome health. Continuous research is needed to refine research and aid in the development of more effective strategies to prevent paediatric IBD.
- Thacker N, et al. Antibiotics, urban environment and western diet pattern increase risk of paediatric inflammatory bowel disease: a meta-analysis. Lecture 350, DDW 2023, 6–9 May, Chicago, IL, USA.
Copyright ©2023 Medicom Medical Publishers
Posted on
Previous Article
« Ulcerative colitis: bowel urgency remission associated with improvement in fatigue Next Article
EVOLVE Expansion study: vedolizumab and ustekinumab as first-line biologic treatments for Crohn’s disease »
« Ulcerative colitis: bowel urgency remission associated with improvement in fatigue Next Article
EVOLVE Expansion study: vedolizumab and ustekinumab as first-line biologic treatments for Crohn’s disease »
Table of Contents: DDW 2023
Featured articles
EVOLVE Expansion study: vedolizumab and ustekinumab as first-line biologic treatments for Crohn’s disease
PIPAC technique shows promise for unresectable colorectal peritoneal metastases
Upper GI Disorders: Hot Topics
Dupilumab improves eosinophilic oesophagitis outcomes, regardless of history of oesophageal dilation
Inflammatory Bowel Disease: Novel Developments
EVOLVE Expansion study: vedolizumab and ustekinumab as first-line biologic treatments for Crohn’s disease
Environmental and dietary factors can amplify paediatric IBD risk
Ulcerative colitis: bowel urgency remission associated with improvement in fatigue
Crohn’s disease: Upadacitinib improves endoscopic outcomes in participants with or without previous biologic failure
Microbiota in GI Diseases
Durability of SER-109 clinical response in patients with recurrent Clostridioides difficile infection
IBS management: the complex role of dietary fibres
Daily and seasonal fluctuations in the gut microbiome
Spotlight on Colorectal Cancer
Colorectal cancer: Aspirin and NSAIDs could reduce the risk of early-onset adenomas
PIPAC technique shows promise for unresectable colorectal peritoneal metastases
What is New in Hepatology?
Terlipressin shows promise for participants with hepatorenal syndrome and concomitant alcoholic hepatitis
Related Articles
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy